Accumulated Other Comprehensive Income (Loss)

12 Months Ended

Dec. 31, 2019

Accumulated Other Comprehensive Income (Loss)

21. Accumulated Other Comprehensive Income (Loss)

The following tables reflect the changes in accumulated other comprehensive income (loss) by component (in thousands):

	Gains and (Losses) on			Foreign Currency			Adjustment to Early
	Hedging Derivatives			Gains (Losses)			Retiree Medical Plan			Total
December 31, 2018	$	(6,500	)	$	(304,646	)	$	7,013		$	(304,133	)
Other comprehensive income (loss) before reclassifications		(9,833	)		7,873			(1,148	)		(3,108	)
Amounts reclassified from accumulated other comprehensive income (loss) into earnings ⁽¹⁾		2,333			—			57			2,390
Net current-period other comprehensive income (loss)		(7,500	)		7,873			(1,091	)		(718	)
Other								1,885			1,885
December 31, 2019	$	(14,000	)	$	(296,773	)	$	7,807		$	(302,966	)

(1)

Includes $2,333 and 57 net-of-tax impact of accumulated other comprehensive income reclassifications into cost of products sold for net losses on commodity contracts and adjustment to early retiree medical plan, respectively. The tax impacts of these reclassifications were $700 and $49, respectively.

	Gains and (Losses) on			Foreign Currency			Adjustment to Early
	Hedging Derivatives			Gains (Losses)			Retiree Medical Plan			Total
December 31, 2017	$	(2,800	)	$	(257,513	)	$	5,632		$	(254,681	)
Other comprehensive income (loss) before reclassifications		(3,568	)		(47,133	)		1,731			(48,970	)
Amounts reclassified from accumulated other comprehensive income (loss) into earnings ⁽²⁾		(132	)		—			(350	)		(482	)
Net current-period other comprehensive income (loss)		(3,700	)		(47,133	)		1,381			(49,452	)
December 31, 2018	$	(6,500	)	$	(304,646	)	$	7,013		$	(304,133	)

(2)

Includes ($132) and ($350) net-of-tax impact of accumulated other comprehensive income reclassifications into cost of products sold for net losses on commodity contracts and adjustment to early retiree medical plan, respectively. The tax impacts of these reclassifications were $0 and ($108), respectively.

Included in the $296.8 million foreign currency losses at December 31, 2019 are $182.0 million of losses related to our equity method investment in Duferdofin Nucor and $114.8 million of losses related primarily to our Canadian operations.